跳至主要内容
临床试验/NCT02676973
NCT02676973进行中(未招募)不适用

Three Arm Apical Suspension Trial for Post-Hysterectomy Vault Prolapse: Prospective Randomized Trial Involving Sacral Colpopexy, Transvaginal Mesh and Native Tissue Apical Repair

NICHD Pelvic Floor Disorders Network20 个研究点 分布在 1 个国家目标入组 360 人开始时间: 2016年2月29日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
360
试验地点
20
主要终点
Number of Participants Considered Failures

研究概览

简要总结

The study is a multi-center, randomized, surgical trial of women with symptomatic post-hysterectomy apical (cuff) prolapse desiring surgical treatment. This study will compare the three available surgical treatments performed in usual practice. The purpose of this study is to compare two commonly performed mesh apical repair (sacral colpopexy vs. Apical Transvaginal Mesh) and vaginal native tissue apical repairs with mesh reinforced repairs. The primary outcome is measured over time (up to 60 months) using a survival analysis approach. Participants will be followed for at least 36-months (3-years) post surgery and up to a maximum of 60-months (5-years) during the primary trial. Participants who complete the primary trial will be approached for consent for long-term follow-up as part of a study extension and will be followed up to a maximum of 120-months (10-years).

The investigators hypothesize that treatment failure will not differ between vaginally and abdominally placed mesh for vault vaginal prolapse, and mesh repairs (regardless of route of implantation) will be superior to native tissue apical suspension.

详细描述

The primary purpose of this three arm randomized clinical trial is to determine if apical transvaginal mesh placement is non-inferior to sacral colpopexy for anatomic correction of post-hysterectomy vaginal vault prolapse and to determine if mesh reinforced repairs performed by abdominal or vaginal approach are superior to native tissue vaginal repair. This trial has the following primary aims:

1. To determine if Apical Transvaginal Mesh is non-inferior to Sacral Colpopexy for anatomic correction of post-hysterectomy vaginal vault prolapse at time points through 3 years.

1A. In the case where Apical Transvaginal Mesh is shown to be statistically significantly non-inferior to Sacral Colpopexy for anatomic correction of post-hysterectomy vaginal vault prolapse at time points through 3 years, to determine if Apical Transvaginal Mesh is superior to Sacral Colpopexy for anatomic correction of post-hysterectomy vaginal vault prolapse at time points through 3 years.

2. To determine if Sacral Colpopexy is superior to Native Tissue Repair for anatomic correction of post-hysterectomy vaginal vault prolapse at time points through 3 years.

3. To determine if Apical Transvaginal Mesh is superior to Native Tissue Repair for anatomic correction of post-hysterectomy vaginal vault prolapse at time points through 3 years.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women age 21 or older
  • Prior total hysterectomy (no cervix present)
  • Prolapse beyond the hymen (defined as Ba, C, or Bp > 0 cm)
  • Vaginal cuff descent into at least the lower two thirds of the vagina (defined as point C> -2/3 TVL)
  • Bothersome bulge symptoms as indicated on question 3 of the PFDI-20 form relating to 'sensation of bulging' or 'something falling out'
  • Desires surgical treatment for post-hysterectomy vaginal prolapse
  • Available for up to 60 month follow-up

排除标准

  • Previous synthetic material or biologic grafts (placed vaginally or abdominally) to augment POP repair including anterior, posterior and/or apical compartments
  • Known previous formal SSLS performed for either uterovaginal or post-hysterectomy vaginal vault prolapse *
  • Known adverse reaction to synthetic mesh or biological grafts; these complications include but are not limited to erosion, fistula, or abscess
  • Unresolved chronic pelvic pain-active
  • Prior abdominal or pelvic radiation
  • Contraindication to any of the index surgical procedures
  • Known Horseshoe Kidney or Pelvic Mass overlying the sacrum
  • Active diverticular abscess or active diverticulitis
  • Shortened vaginal length (<6 cm TVL)
  • Only documented SSLS will be an exclusion.
  • Mesh used for only mid-urethral sling will NOT be an exclusion
  • If prior POP repair is unknown and unable to be documented, subjects will be eligible based on clinician judgment. The investigator will examine and assess for evidence of mesh or graft if no evidence of mesh or graft is present on examination subject remains eligible.

研究组 & 干预措施

Sacral Colpopexy

Active Comparator

Sacral Colpopexy performed via open, robotic, or laparoscopic procedure.

干预措施: Open, Robotic, or Laparoscopic (Procedure)

Transvaginal Native Tissue Repair

Active Comparator

Transvaginal Native Tissue Repair: Sacrospinous Ligament Suspension (SSLS) and Uterosacral Ligament Suspension (USLS)

干预措施: Transvaginal Native Tissue Repair (Procedure)

Apical Transvaginal Mesh Repair

Active Comparator

Uphold™ LITE

干预措施: Uphold™ LITE (Procedure)

结局指标

主要结局

Number of Participants Considered Failures

时间窗: 6 months through 60 Months

Failure was defined as any of the following: retreatment for prolapse, any POP-Q measure beyond the hymen, or presence of bother on PFDI vaginal bulge question. Under the permanent failure state assumption, the number of participants shown at each visit includes all participants who were still participating in the study or had a failure outcome prior their withdrawal. Similarly, the denominator number of participants for the cumulative failure at each visit includes all participants who were still participating in the study and attended the visit or had any failure outcome prior their withdrawal or missed visit.

次要结局

未报告次要终点

研究者

发起方
NICHD Pelvic Floor Disorders Network
申办方类型
Network
责任方
Sponsor

研究点 (20)

Loading locations...

相似试验